Published
During the press conference, Ella hailed the decision of the Indian drug regulator to approve Covaxin for emergency restricted use and termed it as a giant leap for innovation and novel product development in India. Covaxin, India's indigenous COVID-19 vaccine by Bharat Biotech, is developed in collaboration with ICMR.
- Category
- Asia
- Tags
- coronavirus, corona, corona vaccine
Sign in or sign up to post comments.
Be the first to comment
Up Next
Autoplay
-
05:58
UP Elections: Will Akhilesh Yadav be able to grab his throne back in third phase? | Master Stroke
-
02:55
Covaxin 77.8% Effective In Phase 3 Trial Data: Sources
-
01:06
UP Elections 2022 First Phase: Top 5 Highlights | Master Stroke
-
22:11
Corona Crisis: DCGI approves phase II & III trial of Covaxin for kids
-
20:09
Coronavirus: Facts Vs Myths | Covaxin Safe, Phase 3 Results Needed: Lancet
-
02:17
Covid-19 Vaccine: Covaxin Phase 3 Trial Data Shared With Expert Panel Which Meets Today
-
07:46
UP Elections 2022: Why 3rd phase of voting is 'Agni Pariksha' for Akhilesh Yadav? | Master Stroke
-
09:36
Bhopal: Volunteer dies during 3rd phase Covaxin trial, Bharat Biotech issues clarification
-
02:23
Bharat Biotech Enrols Over 25,000 Volunteers For Covaxin Phase 3 Trial
-
02:42
Covaxin Shows Interim Efficacy Of 81% In Phase 3 Results: Bharat Biotech
-
11:17
UP Elections 2022 First Phase Polling: आज का वोट प्रतिशत क्या कहता है? | Master Stroke
-
17:09
Third phase trial results of Covaxin to release soon | Master Stroke
-
03:16
UP Elections: Will third phase of voting be an ordeal for Akhilesh Yadav? | Master Stroke
-
05:46
AMU Vice-Chancellor Registers Himself As First Volunteer Of Covaxin Phase-3 Trial
-
08:22
ABP News journalist takes Covaxin shot, shares experience | Master Stroke
-
07:47
Covaxin Interim Results 'Encouraging', Phase 3 Trials To Continue: AIIMS Chief
-
06:33
HP Elections Results: हिमाचल में किस्सा CM की कुर्सी का! | Master Stroke
-
35:22
DCGI allows Phase II-III clinical trial of Covaxin on 2 to 18-years-old
-
03:18
No side-effects after 30 hrs of Covaxin shot, shares ABP journalist | Master Stroke
-
10:26
Covid-19 Vaccine: Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8% Efficacy
-
09:11
Covaxin Phase 1 Trial Clears Lancet Review, Phase 3 Trial Ongoing
-
05:49
HP Elections Results: हिमाचल में BJP की हार का विश्लेषण! | Master Stroke
Loading...